and: Florence Irving Associate Professor of Medicine, College of Physicians and Surgeons (home dept.)
Dr. R. Graham Barr's research is primarily in respiratory epidemiology, relating to risk factors for asthma and chronic obstructive pulmonary disease (COPD). He has evaluated hormonal and analgesic risk factors for asthma and COPD in the Nurses' Health Study and is currently evaluating usage of over-the-counter analgesic drugs during asthma exacerbations. He is principal investigator (PI) of a longitudinal cohort study of fish oil intake and COPD among current and former smokers. He is co-PI of the Columbia Field Center of the MultiEthnic Study of Atherosclerosis, a 10-year prospective cohort study funded by NHLBI, PI of Mesa-Lung, a large study of endothelial function and lung function in that cohort, and PI at Columbia Mesa-Air, a 10-year prospective study on the health effects of air pollution funded by the EPA.
Robert Wood Johnson Generalist Physician Faculty Scholar, 2001
Irving Scholar Award, Irving Center for Clinical Research, 2004
Selected New York City Activities:
Poverty and Tuberculosis
Dr. Barr analyzed neighborhood poverty and the resurgence of tuberculosis that New York City experienced from 1984 to 1992.
Pesticide Spraying for West Nile Virus and Asthma
Dr. Barr investigated the spraying of pesticide for West Nile Virus control and emergency department asthma visits in New York City.
Selected Global Activities:
Economic Analysis of Tuberculosis Control
Dr. Barr evaluated the cost effectiveness of scaled-up intensive (directly observed therapy) treatment for tuberculosis in 3 developing countries on medical and economic costs in those countries and in the U.S. and Canada.
Countries: Canada; Dominican Republic; Haiti; Mexico
Barr RG, Menzies R The effect of war on tuberculosis: results of a tuberculin survey among displaced persons in El Salvador and a review of the literature Tubercle and Lung Disease 75 251-9 1994
Pablos-Méndez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR Nonadherence in tuberculosis treatment: predictors and consequences in New York City The American Journal of Medicine 102 164-70 1997
Pablos-Méndez A, Barr RG, Shea S Run-in periods in randomized trials: implications for the applicability of results to clinical practice Journal of the American Medical Association 279 222-25 1998
Barr RG, Diez-Roux AV, Knirsch CA, Pablos-Mendez A Neighborhood poverty and the resurgence of tuberculosis in New York City, 1984 to 1992 American Journal of Public Health 91 1487-93 2001
Barr RG, Cooper DM, Speizer FE, Drazen JM, Camargo CA Jr. b2-receptor gene polymorphism and body mass index are associated with asthma in sedentary but not active women Chest 120 1474-9 2001
Barr RG, Nathan DM, Meigs JB, Singer DE Tests of glycemia for the diagnosis of
diabetes mellitus in non-pregnant adults Annals of Internal Medicine 137 263-72 2002
Barr RG, Herbstman J, Speizer FE, Camargo CA Jr. Validation of self-reported chronic obstructive pulmonary disease in a prospective cohort study of women American Journal of Epidemiology 155 965-71 2002
Barr RG, Rowe BH, Camargo CA Jr. Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials British Medical Journal 327 643-46 2003
Barr RG, Wentowski CC, Grodstein F, Somers SC, Stampfer MJ, Schwartz J, Speizer FE, Camargo CA Jr. Prospective study of postmenopausal hormone use and asthma or chronic obstructive pulmonary disease Archives of Internal Medicine 164 379-86 2004
Barr RG, Wentowski CC, Curhan GC, Somers SC, Stampfer MJ, Schwartz J, Speizer FE, Camargo CA Jr. Prospective study of acetaminophen use and newly diagnosed asthma among women American Journal of Respiratory and Critical Care Medicine 169 836-41 2004